Boston Partners’s Ingevity NGVT Stock Holding History
Bought
Maintained
Sold
Other funds holding NGVT
VPM
VCM
SBH
SCM
Boston Partners's NGVT Position: Q1 2026 in Review
Boston Partners reduced its Ingevity (NGVT) stake by 39% in Q1 2026, selling an estimated $16.4M and leaving 379,999 shares worth $27.1M. The position accounts for 0.03% of the portfolio, ranked #339.
Boston Partners first reported a position in NGVT in Q1 2020 and has held it in 18 quarters since. The position peaked at $189M in Q2 2021. 307 funds tracked by Wall St. Rank hold NGVT as of Q1 2026.
- Boston Partners held 379,999 shares of Ingevity worth $27.1M as of Q1 2026.
- Boston Partners sold 240,361 Ingevity shares in Q1 2026, an estimated $16.4M.
- Ingevity made up 0.03% of Boston Partners's portfolio in Q1 2026, its #339 holding.
- Boston Partners first reported a position in Ingevity in Q1 2020 and has held it in 18 quarters since.
- Boston Partners's Ingevity position peaked at $189M in Q2 2021.
- 307 funds tracked by Wall St. Rank held Ingevity as of Q1 2026.
Based on Boston Partners's 13F filing for Q1 2026, filed 11 May 2026.